03/12/2024 5:41 PM | AULIN SHERRY (Reporting) Xenon Pharmaceuticals (Issuer) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:42 PM | Von Seggern Christopher (Reporting) Xenon Pharmaceuticals (Issuer) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:33 PM | MORTIMER IAN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:34 PM | DiFabio Andrea (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:35 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:37 PM | EMPFIELD JAMES R. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 7:09 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:47 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 4:28 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:31 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:03 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 6:04 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:12 AM | Avoro Capital Advisors LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 6:43 AM | DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/02/2024 3:41 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:04 PM | AZAB MOHAMMAD (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 8:50 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4/A | |
12/15/2023 4:38 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 7:02 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:05 PM | Xenon Pharmaceuticals (Filer)
| Form 424B5 | |
11/27/2023 6:03 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 3:27 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/24/2023 3:33 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 5:40 PM | Cannon Gillian (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/10/2023 5:56 PM | Cannon Gillian (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:00 PM | Gover Justin D. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/10/2023 6:05 PM | Gover Justin D. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:20 PM | Machado Patrick (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:21 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:22 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:24 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:25 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:27 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 4:29 PM | AZAB MOHAMMAD (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 6:25 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 6:09 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
05/31/2023 7:11 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023 6:31 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/26/2023 6:10 PM | MORTIMER IAN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 6:05 PM | MORTIMER IAN (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023 3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |